Acurian - Clinical Trial Opportunities, News and Drug... -
[Cached Version]
Published on: 4/22/2004
Last Visited: 4/22/2004
Mark Eisenach
...
Mark Eisenach, Chief Executive Officer, Acurian
Mark brings more than a decade of experience in the healthcare and high technology industries to his role as CEO.Prior to joining Acurian, Mark held a variety of senior executive positions at Covance Inc., one of the world's largest and most comprehensive drug development services companies.In these roles, he led Covance's worldwide business strategy, mergers and acquisitions, business partnerships and global marketing efforts, serving on the company's Global Leadership Council and reporting directly to the CEO.In 1999, Mark founded and served as Chief Operating Officer of Nexigent Inc., Covance's e-business subsidiary for the development of technology-enabled clinical trial services, which he built into a 100-person organization generating multi-million dollar revenues in its first year.
Mark is a graduate of Harvard College and of the Harvard Business School.